[Corrigendum] CCL22 and IL‑37 inhibit the proliferation and epithelial‑mesenchymal transition process of NSCLC A549 cells
Affiliations: Department of Clinical Laboratory, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China, Department of Interventional Ward, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China, Department of Clinical Immunology, Institute of Laboratory Medicine, Guangdong Medical College, Dongguan 523808, P.R. China, Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Dongguan 523808, P.R. China, Department of Pathology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China, Department of Orthopedics, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China
- Published online on: December 16, 2020 https://doi.org/10.3892/or.2020.7903
- Pages: 786-786
Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Oncol Rep 36: [Related article:] 2017-2024, 2016; DOI: 10.3892/or.2016.4995
Subsequently to the publication of the above paper, the authors have drawn to our attention that, owing to errors made in the compilation of the images in Fig. 6, the images shown in Fig. 6A-C in the article were selected incorrectly (essentially, the images shown in Fig. 6A and B were alterative presentations of the same data shown in Fig.. 6C).
Morphological changes in the A549 cells during EMT were observed by microscopy (A, the control; B, the pDsRed-N1 blank plasmid; C, the pEGFP-C1 blank plasmid; D, the pDsRed-CCL22 plasmid; E, the pEGFP-IL-37 plasmid; and F, the pDsRed-CCL22 + pEGFP-IL-37 plasmid group).
The authors were able to re-examine the original data files and retrieve the correct data panels. The revised version of Fig. 6, featuring the corrected data panels for Fig. 6A-C, is shown opposite. Note that the revisions made to this figure do not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.